Stay updated on Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial
Sign up to get notified when there's something new on the Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial page.

Latest updates to the Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial page
- Check5 days agoChange DetectedThe page footer revision/version was updated from “v3.5.2” to “v3.5.3,” reflecting a site release update rather than a study content change.SummaryDifference0.1%

- Check12 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check42 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check49 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be an internal version update and does not modify study data or user-facing features.SummaryDifference0.0%

- Check77 days agoChange DetectedAdded Revision: v3.4.2. Removed the older notices, including the government funding lapse message and the Revision: v3.4.1 reference.SummaryDifference0.4%

- Check84 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH Clinical Center status, with links for updated operating information (cc.nih.gov and opm.gov). Updated the page revision tag from v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial page.